Cellebrite DI Ltd.
CLBTNASDAQTechnologySoftware - Infrastructure
As of Oct 16, 2026 close
- Market cap
- $2.88B
- P/E (TTM)
- 48.96
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $9.58$19.98
- Volume (live)
- -
- Avg. volume (3M)
- 2.55M
Cellebrite DI (CLBT) Stock Price & Financial Analysis
Cellebrite DI Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.85 - $11.48 |
|---|---|
| 52-Week High | $19.98 |
| 52-Week Low | $9.58 |
| Open | $11.45 |
| Volume (last close) | 1.53M |
| Average Volume (3M) | 2.55M |
| Revenue (TTM) | 514.29M |
|---|---|
| Net Income (TTM) | 58.76M |
| Free Cash Flow (TTM) | 132.53M |
| EPS (TTM) | $0.23 |
| Profit Margin | 11.43% |
| Operating Margin | 10.86% |
| Return on Equity (ROE) | 10.92% |
| Debt to Equity | 0.04 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 2.88B |
|---|---|
| Shares Outstanding | 252.79M |
| P/E Ratio (TTM) | 48.96 |
| Price to Sales (P/S) | 5.59 |
| Price to Book (P/B) | 5.35 |
| EV/EBITDA | 25.62 |
| 50-Day MA | $11.89 |
|---|---|
| 200-Day MA | $13.79 |
| 1-Year Change | −37.40% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Cellebrite DI at a Glance
As of the Oct 16, 2026 close, Cellebrite DI (CLBT) has a market capitalization of $2.88B. The stock trades at 49.0× trailing earnings and 5.6× sales. Over the trailing twelve months it earned $58.76M on revenue of $514.29M (a 11.4% profit margin) and generated $132.53M of free cash flow. Revenue grew 17.8% year over year.
As of its latest reported balance sheet, it holds $141.25M in cash and securities against $23.23M of debt, a net cash position of $118.02M.
Cellebrite DI does not currently pay a dividend.
The share price is down 37.4% over the past year. At $11.03 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $9.58 to $19.98, below its 200-day moving average of $13.79.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $14.58, 32.2% above the Oct 16, 2026 close.
Frequently Asked Questions About Cellebrite DI
What is the current stock price for CLBT?
As of the Oct 16, 2026 close, CLBT stock trades at $11.03. The 52-week range is $9.58–$19.98, with a day range of $10.85–$11.48.
What is the P/E ratio for CLBT?
As of the Oct 16, 2026 close, Cellebrite DI's trailing twelve-month (TTM) P/E ratio is 49.0, meaning investors pay $49.0 for every $1 of annual earnings. Cellebrite DI operates in the Technology sector.
Does CLBT pay dividends?
Cellebrite DI does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for CLBT?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for CLBT is Buy. The average 12-month price target is $14.58, a 32.2% upside from the Oct 16, 2026 close of $11.03.
What is the market cap of CLBT?
As of the Oct 16, 2026 close, Cellebrite DI's market capitalization is $2.79B, classifying it as a mid-cap company. Cellebrite DI operates in the Technology sector within the Software - Infrastructure industry.